| Lydia A White, MD | |
|
1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129-2567 | |
| (615) 896-6800 | |
| (615) 895-8890 |
| Full Name | Lydia A White |
|---|---|
| Gender | Female |
| Speciality | Sports Medicine |
| Experience | 18 Years |
| Location | 1800 Medical Center Pkwy, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477754992 | NPI | - | NPPES |
| 003715400 | Medicaid | FL | |
| 129763 | Medicaid | AL | |
| 129762 | Medicaid | AL | |
| 14E79 | Other | FL | BLUE CROSS BLUE SHIELD |
| 593-07438 | Other | AL | BLUE CROSS BLUE SHIELD |
| 593-07437 | Other | AL | BLUE CROSS BLUE SHIELD |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Orthopaedic Alliance Pa | 5193625069 | 308 |
News Archive
Consumer Watchdog condemned the removal of the Medicare buy-in provision for those over 55 and the public option from the U.S. Senate health reform bill. But the group said that the Senate must still make three essential fixes to the greatly weakened bill to prevent ceding the entire health care system to the insurance industry.
In May 2019, the U.S. Food and Drug Administration approved a gene replacement therapy for the inherited, progressive neuromuscular disease 5q-linked spinal muscular atrophy.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
Very small differences in the way a patient lies during radiotherapy treatment for lung or oesophageal cancer can have an impact on how likely they are to survive, according to research presented at the ESTRO 37 conference.
Severe inflammation in tissues is often associated with the occurrence of cancer. The mechanism linking both these conditions is not clearly understood. Furthermore, inflamed and cancerous tissues contain a heterogenous mix of damaged and protective cells.
› Verified 4 days ago
| Entity Name | Tennessee Orthopaedic Alliance Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538153937 PECOS PAC ID: 5193625069 Enrollment ID: O20040109000069 |
News Archive
Consumer Watchdog condemned the removal of the Medicare buy-in provision for those over 55 and the public option from the U.S. Senate health reform bill. But the group said that the Senate must still make three essential fixes to the greatly weakened bill to prevent ceding the entire health care system to the insurance industry.
In May 2019, the U.S. Food and Drug Administration approved a gene replacement therapy for the inherited, progressive neuromuscular disease 5q-linked spinal muscular atrophy.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
Very small differences in the way a patient lies during radiotherapy treatment for lung or oesophageal cancer can have an impact on how likely they are to survive, according to research presented at the ESTRO 37 conference.
Severe inflammation in tissues is often associated with the occurrence of cancer. The mechanism linking both these conditions is not clearly understood. Furthermore, inflamed and cancerous tissues contain a heterogenous mix of damaged and protective cells.
› Verified 4 days ago
| Entity Name | Select Health Of Sc, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962904946 PECOS PAC ID: 7416212972 Enrollment ID: O20210623003548 |
News Archive
Consumer Watchdog condemned the removal of the Medicare buy-in provision for those over 55 and the public option from the U.S. Senate health reform bill. But the group said that the Senate must still make three essential fixes to the greatly weakened bill to prevent ceding the entire health care system to the insurance industry.
In May 2019, the U.S. Food and Drug Administration approved a gene replacement therapy for the inherited, progressive neuromuscular disease 5q-linked spinal muscular atrophy.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
Very small differences in the way a patient lies during radiotherapy treatment for lung or oesophageal cancer can have an impact on how likely they are to survive, according to research presented at the ESTRO 37 conference.
Severe inflammation in tissues is often associated with the occurrence of cancer. The mechanism linking both these conditions is not clearly understood. Furthermore, inflamed and cancerous tissues contain a heterogenous mix of damaged and protective cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lydia A White, MD Po Box 306556, Nashville, TN 37230-6556 Ph: (865) 243-8153 | Lydia A White, MD 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129-2567 Ph: (615) 896-6800 |
News Archive
Consumer Watchdog condemned the removal of the Medicare buy-in provision for those over 55 and the public option from the U.S. Senate health reform bill. But the group said that the Senate must still make three essential fixes to the greatly weakened bill to prevent ceding the entire health care system to the insurance industry.
In May 2019, the U.S. Food and Drug Administration approved a gene replacement therapy for the inherited, progressive neuromuscular disease 5q-linked spinal muscular atrophy.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
Very small differences in the way a patient lies during radiotherapy treatment for lung or oesophageal cancer can have an impact on how likely they are to survive, according to research presented at the ESTRO 37 conference.
Severe inflammation in tissues is often associated with the occurrence of cancer. The mechanism linking both these conditions is not clearly understood. Furthermore, inflamed and cancerous tissues contain a heterogenous mix of damaged and protective cells.
› Verified 4 days ago
Dr. Edwin Ray Lowery, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1010 N Highland Ave, Murfreesboro, TN 37130 Phone: 615-896-6800 Fax: 615-320-1229 | |
Nicholas Alan Shepard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Dr. William Henry Ledbetter, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 | |
Dr. Kyle Steven Joyner, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Dr. James Lundin Rungee, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Dr. Brad Michael Askam, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Dr. Richard Alan Rogers, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 |